about
HMGB1-DNA complex-induced autophagy limits AIM2 inflammasome activation through RAGEPPAR Ligands Function as Suppressors That Target Biological Actions of HMGB1High mobility group protein 1: A collaborator in nucleosome dynamics and estrogen-responsive gene expressionUntil Death Do Us Part: Necrosis and Oxidation Promote the Tumor MicroenvironmentNovel concepts on pregnancy clocks and alarms: redundancy and synergy in human parturitionNK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy?Role of Redox Status in Development of GlioblastomaInvolvement of HMGB1 in Resistance to Tumor Vessel-Targeted, Monoclonal Antibody-Based ImmunotherapyCirculating HMGB1 and RAGE as Clinical Biomarkers in Malignant and Autoimmune DiseasesInnate immunity and hepatocarcinoma: Can toll-like receptors open the door to oncogenesis?High Mobility Group B Proteins, Their Partners, and Other Redox Sensors in Ovarian and Prostate CancerThe Role of HMGB1 Signaling Pathway in the Development and Progression of Hepatocellular Carcinoma: A ReviewPrognostic and Predictive Value of DAMPs and DAMP-Associated Processes in CancerCell death and DAMPs in acute pancreatitisOxidative stress-mediated HMGB1 biologyEmerging roles for HMGB1 protein in immunity, inflammation, and cancerClinical Value of High Mobility Group Box 1 and the Receptor for Advanced Glycation End-products in Head and Neck Cancer: A Systematic ReviewHijacker of the Antitumor Immune Response: Autophagy Is Showing Its Worst FacetInterplay between ROS and autophagy in cancer cells, from tumor initiation to cancer therapyDifferent Toll-Like Receptor Expression Patterns in Progression toward CancerInflammatory Response After Laparoscopic Versus Open Resection of Colorectal Liver Metastases: Data From the Oslo-CoMet TrialEmerging role of HMGB1 in lung diseases: friend or foe.Triple helix-interacting proteins and cancer.High mobility group box 1 antagonist limits metastatic seeding in the lungs via reduction of cell-cell adhesion.A functional variant at the miRNA binding site in HMGB1 gene is associated with risk of oral squamous cell carcinoma.MIR34A regulates autophagy and apoptosis by targeting HMGB1 in the retinoblastoma cell.Pathological features of triple-negative breast cancers that showed progressive disease during neoadjuvant chemotherapyTargeting autophagy in breast cancer.High mobility group box 1 (HMGB1) phenotypic role revealed with stress.Local and systemic RAGE axis changes in pulmonary hypertension: CTEPH and iPAHCREB-induced inflammation is important for malignant mesothelioma growth.Integrated transcriptional profiling and genomic analyses reveal RPN2 and HMGB1 as promising biomarkers in colorectal cancer.HMGB1 in health and disease.Failure of anti tumor-derived endothelial cell immunotherapy depends on augmentation of tumor hypoxia.The quantum of initial transformed cells potentially modulates the type of local inflammation mechanism elicited by surrounding normal epithelial tissues and systemic immune pattern for tumor arrest or progression.High mobility group box-1 and its clinical value in breast cancer.Expression of RAGE and HMGB1 in thymic epithelial tumors, thymic hyperplasia and regular thymic morphology.Directional migration of adult hematopoeitic progenitors to C6 glioma in vitro.Autophagy-mediated HMGB1 release promotes gastric cancer cell survival via RAGE activation of extracellular signal-regulated kinases 1/2.High-Mobility Group Box 1 Promotes Hepatocellular Carcinoma Progression through miR-21-Mediated Matrix Metalloproteinase Activity
P2860
Q24299935-2F6532A2-DBF1-4D0A-8D18-9C9D5A80E313Q26738811-3E6D8AE0-F6B9-4616-A881-6A362103F7DDQ26744313-5D7E514B-F1CA-4B47-AE66-B4B82EC77D00Q26745898-154EA164-80DB-45DB-86E4-CFCB6A47E4C6Q26745938-88C1A28F-CE98-4AEA-A08A-EC9EAC6FB644Q26746478-A582C55F-26EE-4B0F-B062-189AE7FB77DBQ26747419-3EC8FEBF-D60A-4D4C-80A8-90A3933B2520Q26765594-2802958D-7245-4546-8921-55CBED503CE0Q26768480-93A999D8-2A90-4339-A556-B4FD849FC82EQ26770029-B8E1CFB8-4E1E-416B-8CCF-BDE3D0242193Q26774902-9D908C1A-C53C-4E1C-93A9-C19110C32F97Q26782281-DFD3F7DE-CAF4-49D8-B875-3E75771D7DD4Q26795466-9CFE318A-7D90-497D-A5C5-61CD50473814Q26994999-FF37668E-B6F3-46C4-8ECD-7185B6B196F6Q27000955-C1342BDF-9815-451B-B0E7-155CC3C16CD0Q27015835-9EC43335-DBE3-4294-9FBB-F152C8FC366FQ28074543-2B4B1314-E942-4DE5-9758-9CAEB96BFDFBQ28079816-A931A193-0AF1-4E13-B1AF-C8FEF9030B46Q28082347-E3C2D1E9-1838-4460-A054-0B845F000B71Q28085163-65CC8B3E-88D0-49D1-9098-3591B19683FBQ31010163-4A3BEA39-9AC0-47FA-B96B-178F08FC5618Q33684145-D8C190A0-2CF6-4B54-829B-8E04243A43EAQ33720531-6F1CFD3D-386C-4D91-B852-2F4D4013018BQ33779216-244D6C12-6C91-4F63-AB0D-693FF7B6ACA5Q33798500-BA19B80F-78DB-4B19-9A38-F2F5472C577BQ33831315-F641038E-E9BA-4A30-B69C-C9A44EA984ADQ33873330-9C4DD30A-2062-4A03-A852-93027A273A6EQ34023616-99B842D0-5711-49D8-AB2E-267773116D6DQ34129779-D72C6595-3B0B-4A7B-B10F-F6353C8FAB0EQ34133874-7A3F3C2F-A295-4943-BFCF-76626632F789Q34302855-C8E0B94D-F895-4F6A-8A8A-D988F8B16021Q34494956-925E857A-8A8A-4105-9B48-C397A56A655AQ34622835-9FC1C0B7-FCE2-4EAC-92D8-76193948D8D5Q34786452-30916258-02E8-44F7-93CE-9C19FA89A281Q34791671-A53A6DFF-0AB7-4870-B979-66368271E0CAQ35101004-D597726E-24A1-4FA6-8DEE-AC1E2E6B31D3Q35140467-A9EDE2D7-0FA7-414E-B3C7-4A4ABA070BA9Q35167725-C0657FEE-8AEC-49FC-B4F4-8444BA58CBB3Q35172545-4E17EAE5-FDEE-4417-AD62-AF82E68896C5Q35463638-B078943B-9BA7-45C5-AC20-2317B619AC74
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 May 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
HMGB1 in cancer: good, bad, or both?
@en
HMGB1 in cancer: good, bad, or both?
@nl
type
label
HMGB1 in cancer: good, bad, or both?
@en
HMGB1 in cancer: good, bad, or both?
@nl
prefLabel
HMGB1 in cancer: good, bad, or both?
@en
HMGB1 in cancer: good, bad, or both?
@nl
P2093
P2860
P1476
HMGB1 in cancer: good, bad, or both?
@en
P2093
Daolin Tang
Herbert J Zeh
Michael T Lotze
Qiuhong Zhang
P2860
P304
P356
10.1158/1078-0432.CCR-13-0495
P407
P577
2013-05-30T00:00:00Z